Zhitong Finance App News, Tianjin Pharmaceutical (600488.SH) issued an announcement. Recently, the company's subsidiary Hubei Jinyao Pharmaceutical Co., Ltd. received the “Drug Registration Certificate” for compound amino acid injections (18AA-VII) approved and issued by the State Drug Administration. Compound amino acid injection (18AA-VII) is used for hypoproteinemia, undernutrition, and amino acid supplementation before and after surgery. The drug is declared according to the 4 types of chemical registration. After approval, it is treated as if it has passed the consistent evaluation of the quality and efficacy of generic drugs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.